Vitamin D deficiency and its association with fatigue and quality of life in multiple sclerosis patients
- 12 Downloads
Vitamin D deficiency is associated with the incidence and prevalence of a variety of neurologic disorders, including multiple sclerosis. However, available studies to date have not provided convincing evidence that vitamin D treatment improves fatigue and life quality in patients with multiple sclerosis.
To assess the relationship of vitamin D deficiency with health-related quality-of-life issues and fatigue in multiple sclerosis patients.
Vitamin D3 levels were measured in 149 multiple sclerosis patients. In patients with lower than 30 ng/mL levels, vitamin D was administered. Fatigue and health-related quality of life scores were measured at baseline and months 1, 3, 6, and 12 after the beginning of vitamin D3 administration.
Among 149 patients, 90% were vitamin D deficient. After vitamin D supplementation, health-related quality of life and fatigue scores improved significantly. There was a direct association between health-related quality of life with absence of fatigue and vitamin D status at the end of study.
The 90% frequency of multiple sclerosis patients with vitamin D deficiency, together with the significant association of vitamin D status with the absence of fatigue and improved physical and functional well-being, points to vitamin D supplementation as a potential therapy to enhance the patient’s quality of life.
Relevance of the article for predictive, preventive, and personalized medicine
This article emphasizes that vitamin D supplementation can improve clinical outcome in multiple sclerosis patients providing immune modulation and neuroprotection. Identification and correction of vitamin D deficiency has the potential to treat the related quality of life in patients with multiple sclerosis.
Keywordspredictive preventive personalized medicine multiple sclerosis vitamin D health-related quality of life fatigue
The authors (Yesim Beckmann and Sabiha Ture) contributed equally to the manuscript.
Compliance with ethical standards
The authors declare that they have no competing interests.
The research did not involve any risk for the participants. All ethical guidelines were followed as required for conducting human research. The procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional research, the study being approved to be run by the manager of the Izmir Katip Celebi University, where the study was conducted and by the Committee for Ethical Research of Izmir Katip Celebi University (Ethical approval number 307/2016). The research complies with the provisions of the Declaration of Helsinki. All the participants gave their informed consent for the research, and their anonymity was preserved.
Consent for publication
- 20.Pöttgen J, Moss MR, Wendebourg MJ, Feddersen LK, Lau S, Köpke S, Meyer B, Friede T, Penner IK,Heesen C, Gold SM. Randomised controlled trial of a self-guided online fatigue intervention in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2018;1–7.Google Scholar
- 35.Golan D, Halhal B, Glass-Marmor L, Staun-Ram E, Rozenberg O, Lavi I, et al. Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties. BMC Neurol. 2013;13:60.CrossRefGoogle Scholar
- 36.Kampman MT, Steffensen LH, Mellgren SI, Jorgensen L. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double- blind randomised controlled trial. Mult Scler. 2012;18(8):1144–51.CrossRefGoogle Scholar